Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat
- PMID: 19231296
- PMCID: PMC2741410
- DOI: 10.1016/j.jpain.2008.12.003
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat
Abstract
Although platinum-based cancer chemotherapies produce painful peripheral neuropathy as dose-limiting side effects, there are important differences in the pain syndromes produced by members of this class of drugs. In the rat, cisplatin-induced hyperalgesia has latency to onset of 24 to 48 hours, is maximal by 72 to 96 hours, and is attenuated by inhibitors of caspase signaling but not by inhibitors of the mitochondrial electron transport chain (mETC) and antioxidants. In contrast, oxaliplatin-induced mechanical hyperalgesia is already present by 5 minutes and peaks by 20 minutes. Whereas oxaliplatin hyperalgesia persists for weeks, starting around day 10 to 15, its severity decreases to a lower 2nd plateau level. The rapid-onset 1st plateau in oxaliplatin-induced hyperalgesia was characterized by prominent cold allodynia and in contrast to cisplatin was attenuated by inhibitors of the mETC and antioxidants but not inhibitors of caspase signaling. However, tested later during the 2nd plateau, it was characterized by less intense hyperalgesia and no cold allodynia and was attenuated by inhibitors of caspase signaling as well as by inhibitors of the mETC and by antioxidants.
Perspective: The findings of this study distinguish between the neuropathic pain syndromes produced by members of a single chemical class of anticancer drugs and suggest that the underlying mechanisms of various forms of peripheral neuropathy may be different. Further, it defines the need for selective therapy for different types of neuropathy.
Figures



Similar articles
-
Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.J Pain. 2008 May;9(5):463-72. doi: 10.1016/j.jpain.2008.01.335. Epub 2008 Mar 24. J Pain. 2008. PMID: 18359667
-
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.Toxicology. 2007 May 20;234(3):176-84. doi: 10.1016/j.tox.2007.02.013. Epub 2007 Mar 1. Toxicology. 2007. PMID: 17418472
-
Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.Pain. 2009 Dec 15;147(1-3):165-74. doi: 10.1016/j.pain.2009.09.003. Epub 2009 Sep 25. Pain. 2009. PMID: 19782472
-
[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].Yakugaku Zasshi. 2016;136(2):287-96. doi: 10.1248/yakushi.15-00214. Yakugaku Zasshi. 2016. PMID: 26831807 Review. Japanese.
-
Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.Curr Opin Support Palliat Care. 2016 Jun;10(2):119-128. doi: 10.1097/SPC.0000000000000204. Curr Opin Support Palliat Care. 2016. PMID: 27054288 Free PMC article. Review.
Cited by
-
MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice.Neuroscience. 2023 Apr 15;516:54-61. doi: 10.1016/j.neuroscience.2023.02.006. Epub 2023 Feb 17. Neuroscience. 2023. PMID: 36805004 Free PMC article.
-
An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy.Pain Manag. 2018 Sep 1;8(5):363-375. doi: 10.2217/pmt-2018-0020. Epub 2018 Sep 13. Pain Manag. 2018. PMID: 30212277 Free PMC article. Review.
-
Effects of Oxaliplatin on Facial Sensitivity to Cool Temperatures and TRPM8 Expressing Trigeminal Ganglion Neurons in Mice.Front Pain Res (Lausanne). 2022 May 11;3:868547. doi: 10.3389/fpain.2022.868547. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 35634452 Free PMC article.
-
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Neuropsychopharmacology. 2018 Jan;43(1):52-79. doi: 10.1038/npp.2017.204. Epub 2017 Aug 31. Neuropsychopharmacology. 2018. PMID: 28857069 Free PMC article. Review.
-
Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy.Ann Neurol. 2011 Jul;70(1):101-9. doi: 10.1002/ana.22382. Ann Neurol. 2011. PMID: 21786301 Free PMC article.
References
-
- Abrey LE, Correa DD. Treatment-related neurotoxicity. Hematol Oncol Clin North Am. 2005;19:729–738. viii. - PubMed
-
- Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol. 2000;406:25–32. - PubMed
-
- Aley KO, Levine JD. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience. 2002;111:389–397. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical